These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25229772)

  • 1. Grading uterine endometrioid carcinoma: a proposal that binary is best.
    Conlon N; Leitao MM; Abu-Rustum NR; Soslow RA
    Am J Surg Pathol; 2014 Dec; 38(12):1583-7. PubMed ID: 25229772
    [No Abstract]   [Full Text] [Related]  

  • 2. The reproducibility of a binary tumor grading system for uterine endometrial endometrioid carcinoma, compared with FIGO system and nuclear grading.
    Sagae S; Saito T; Satoh M; Ikeda T; Kimura S; Mori M; Sato N; Kudo R
    Oncology; 2004; 67(5-6):344-50. PubMed ID: 15713989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
    Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA
    Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fascin expression in low-grade uterine endometrioid adenocarcinoma: correlation with microcystic, elongated and fragmented (MELF)-type alteration at the deep invasive margin.
    Stewart CJ; Crook ML; Manso L
    Histopathology; 2011 Jul; 59(1):73-80. PubMed ID: 21771028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.
    McIntyre JB; Nelson GS; Ghatage P; Morris D; Duggan MA; Lee CH; Doll CM; Köbel M
    Gynecol Oncol; 2014 Jan; 132(1):188-93. PubMed ID: 24262879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucinous differentiation does not impact stage or risk of recurrence among patients with grade 1, endometrioid type, endometrial carcinoma.
    Worley MJ; Davis M; Berhie SH; Muto MG; Feltmate CM; Berkowitz RS; Horowitz NS; Campos SM
    Gynecol Oncol; 2014 Oct; 135(1):54-7. PubMed ID: 25088333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synchronous occurrence of primary neoplasms of the uterus with mucinous carcinoma of the cervix and endometrioid carcinoma of the endometrium.
    Sun HD; Lai CR; Yen MS; Wang PH
    Taiwan J Obstet Gynecol; 2011 Sep; 50(3):377-8. PubMed ID: 22030058
    [No Abstract]   [Full Text] [Related]  

  • 8. [Endometrial hyperplasia predicts a better prognosis in endometrial carcinoma].
    Mihailovici MS; Teleman S
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(2):367-70. PubMed ID: 14755942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of systematic lymphadenectomy and adjuvant radiation in early-stage endometrioid uterine cancer.
    Jeong NH; Lee JM; Lee JK; Kim MK; Kim YJ; Cho CH; Kim SM; Park SY; Park CY; Kim KT
    Ann Surg Oncol; 2010 Nov; 17(11):2951-7. PubMed ID: 20556522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type.
    Clarke BA; Gilks CB
    J Clin Pathol; 2010 May; 63(5):410-5. PubMed ID: 20418232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium.
    Meng B; Hoang LN; McIntyre JB; Duggan MA; Nelson GS; Lee CH; Köbel M
    Gynecol Oncol; 2014 Jul; 134(1):15-9. PubMed ID: 24844595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Architectural versus nuclear atypia-defined FIGO grade 2 endometrial endometrioid adenocarcinoma (EEC): a clinicopathologic comparison of 154 cases with clinical follow-up.
    Winham WM; Lin D; Stone PJ; Nucci MR; Quick CM
    Int J Gynecol Pathol; 2014 Mar; 33(2):120-6. PubMed ID: 24487465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrioid endometrial adenocarcinoma recurring as carcinosarcoma.
    Shaco-Levy R; Piura B
    J Obstet Gynaecol Res; 2008 Apr; 34(2):279-82. PubMed ID: 18412798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Catenin mutations in recurrent FIGO IA grade I endometrioid endometrial cancers.
    Myers A; Barry WT; Hirsch MS; Matulonis U; Lee L
    Gynecol Oncol; 2014 Aug; 134(2):426-7. PubMed ID: 24952365
    [No Abstract]   [Full Text] [Related]  

  • 15. Parathyroid hormone-related protein-secreting uterine endometrioid adenocarcinoma.
    Kinugasa Y; Morishige K; Kamiura S; Tsukamoto Y; Saji F
    Jpn J Clin Oncol; 2006 Feb; 36(2):113-5. PubMed ID: 16418186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the prognostic significance of uterine factors and nodal status for endometrial cancer.
    Barrena Medel NI; Herzog TJ; Deutsch I; Burke WM; Sun X; Lewin SN; Wright JD
    Am J Obstet Gynecol; 2011 Mar; 204(3):248.e1-7. PubMed ID: 21247552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
    Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
    Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopatological aspects of endometroid carcinoma in correlation to the state of tumoral progression in women patients during their premenopausal period.
    Morărescu MD; Simionescu C; Roşculescu I; Bălă S; Cernea N; Pătru E
    Rom J Morphol Embryol; 2006; 47(1):53-8. PubMed ID: 16838058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
    Alvarez T; Miller E; Duska L; Oliva E
    Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter to the editor in response to "Stage 1, grade 3 endometrioid adenocarcinoma of the endometrium: An analysis of clinical outcomes and patterns of recurrence".
    Pollock J
    Gynecol Oncol; 2010 Jun; 117(3):507; author reply 507-8. PubMed ID: 20189231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.